Literature DB >> 10338371

Corticotrophin-releasing hormone and platelet-activating factor induce transcription of the type-2 cyclo-oxygenase gene in human fetal membranes.

S A Alvi1, N L Brown, P R Bennett, M G Elder, M H Sullivan.   

Abstract

Corticotrophin-releasing hormone (CRH) and platelet-activating factor (PAF) are considered to be involved in the physiological processes of human labour. Both may have dual effects, directly regulating myometrial contractility and fetal membrane prostaglandin production. During this study, we investigated the mechanisms through which CRH and PAF exert their latter effect. CRH and PAF increased prostaglandin production from intact fetal membrane discs, with a maximum stimulation after 8 h of culture. Reverse transcription-polymerase chain reaction (RT-PCR) analyses using primers specific for type-2 cyclo-oxygenase (COX-2) showed that CRH and PAF increased the transcription of COX-2 mRNA two-fold after 8 h culture. These data indicate that the increased fetal membrane prostaglandin production in response to CRH or PAF may involve the induction of COX-2.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10338371     DOI: 10.1093/molehr/5.5.476

Source DB:  PubMed          Journal:  Mol Hum Reprod        ISSN: 1360-9947            Impact factor:   4.025


  6 in total

1.  Platelet-activating factor: a role in preterm delivery and an essential interaction with Toll-like receptor signaling in mice.

Authors:  Varkha Agrawal; Mukesh Kumar Jaiswal; Vladimir Ilievski; Kenneth D Beaman; Tamas Jilling; Emmet Hirsch
Journal:  Biol Reprod       Date:  2014-09-24       Impact factor: 4.285

2.  RelB/NF-κB2 regulates corticotropin-releasing hormone in the human placenta.

Authors:  Bingbing Wang; Nataliya Parobchak; Todd Rosen
Journal:  Mol Endocrinol       Date:  2012-06-25

3.  The production of interleukin-1beta from human fetal membranes is not obligatory for increased prostaglandin output.

Authors:  S A Alvi; D Rajasingam; N L Brown; M G Elder; P R Bennett; M H Sullivan
Journal:  Immunology       Date:  1999-06       Impact factor: 7.397

4.  Nitric oxide (NO) modulation of PAF-induced cardiopulmonary action: interaction between NO synthase and cyclo-oxygenase-2 pathways.

Authors:  F Fabi; R Calabrese; T Stati; P del Basso
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

5.  Toll-Like Receptor-4 Antagonist (+)-Naltrexone Protects Against Carbamyl-Platelet Activating Factor (cPAF)-Induced Preterm Labor in Mice.

Authors:  Hanan H Wahid; Peck Yin Chin; David J Sharkey; Kerrilyn R Diener; Mark R Hutchinson; Kenner C Rice; Lachlan M Moldenhauer; Sarah A Robertson
Journal:  Am J Pathol       Date:  2020-02-18       Impact factor: 4.307

6.  Lipopolysaccharide induces nitric oxide synthase expression and platelet-activating factor increases nitric oxide production in human fetal membranes in culture.

Authors:  Gunter Seyffarth; Paul N Nelson; Simon J Dunmore; Nalinda Rodrigo; Damian J Murphy; Ray J Carson
Journal:  Reprod Biol Endocrinol       Date:  2004-06-10       Impact factor: 5.211

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.